142 related articles for article (PubMed ID: 16604230)
1. Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4.
Row EC; Brown SA; Stachulski AV; Lennard MS
Org Biomol Chem; 2006 Apr; 4(8):1604-10. PubMed ID: 16604230
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 8-geranyloxypsoralen analogues and their evaluation as inhibitors of CYP3A4.
Row EC; Brown SA; Stachulski AV; Lennard MS
Bioorg Med Chem; 2006 Jun; 14(11):3865-71. PubMed ID: 16481174
[TBL] [Abstract][Full Text] [Related]
3. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
4. Development of novel furanocoumarin dimers as potent and selective inhibitors of CYP3A4.
Row E; Brown SA; Stachulski AV; Lennard MS
Drug Metab Dispos; 2006 Feb; 34(2):324-30. PubMed ID: 16299162
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis of Furanocoumarin, Benzofuran and Coumarin Derivatives Possessing an Inhibitory Effect on Human CYP, and Elucidation of the Inhibitory Mechanism].
Yamaguchi Y
Yakugaku Zasshi; 2017; 137(10):1209-1214. PubMed ID: 28966261
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
7. Dihydroxybergamottin caproate as a potent and stable CYP3A4 inhibitor.
Ohta T; Nagahashi M; Hosoi S; Tsukamoto S
Bioorg Med Chem; 2002 Apr; 10(4):969-73. PubMed ID: 11836106
[TBL] [Abstract][Full Text] [Related]
8. Synthetic models related to furanocoumarin-CYP 3A4 interactions. comparison of furanocoumarin, coumarin, and benzofuran dimers as potent inhibitors of CYP3A4 activity.
Oda K; Yamaguchi Y; Yoshimura T; Wada K; Nishizono N
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1419-21. PubMed ID: 17827777
[TBL] [Abstract][Full Text] [Related]
9. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
Malhotra S; Bailey DG; Paine MF; Watkins PB
Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
[TBL] [Abstract][Full Text] [Related]
10. Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel.
Wangensteen H; Molden E; Christensen H; Malterud KE
Eur J Clin Pharmacol; 2003 Feb; 58(10):663-8. PubMed ID: 12610742
[TBL] [Abstract][Full Text] [Related]
11. New grapefruit cultivars exhibit low cytochrome P4503A4-Inhibition activity.
Guttman Y; Yedidia I; Nudel A; Zhmykhova Y; Kerem Z; Carmi N
Food Chem Toxicol; 2020 Mar; 137():111135. PubMed ID: 31968226
[TBL] [Abstract][Full Text] [Related]
12. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
[TBL] [Abstract][Full Text] [Related]
13. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition.
Paine MF; Criss AB; Watkins PB
J Pharmacol Exp Ther; 2005 Mar; 312(3):1151-60. PubMed ID: 15485894
[TBL] [Abstract][Full Text] [Related]
14. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
16. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties.
Paine MF; Criss AB; Watkins PB
Drug Metab Dispos; 2004 Oct; 32(10):1146-53. PubMed ID: 15269184
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.
Ho PC; Saville DJ; Wanwimolruk S
J Pharm Pharm Sci; 2001; 4(3):217-27. PubMed ID: 11737987
[TBL] [Abstract][Full Text] [Related]
18. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.
Bailey DG; Dresser GK; Kreeft JH; Munoz C; Freeman DJ; Bend JR
Clin Pharmacol Ther; 2000 Nov; 68(5):468-77. PubMed ID: 11103749
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines.
Guo LQ; Yamazoe Y
Acta Pharmacol Sin; 2004 Feb; 25(2):129-36. PubMed ID: 14769198
[TBL] [Abstract][Full Text] [Related]
20. A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction.
Paine MF; Widmer WW; Hart HL; Pusek SN; Beavers KL; Criss AB; Brown SS; Thomas BF; Watkins PB
Am J Clin Nutr; 2006 May; 83(5):1097-105. PubMed ID: 16685052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
